Evozac capsules 30mg from Alfresa Pharma (YJ code: 2399012M1026, 30mg 1 capsule) contain cevimeline hydrochloride hydrate, a cholinergic agonist. It is prescribed to treat dry mouth (xerostomia) symptoms in patients with Sjögren’s syndrome by increasing saliva production.
Evozac capsules 30mg
Need more detailed information?
Contact TASAKI PHARMA for product sourcing, availability, or related support (English support available).
